127 related articles for article (PubMed ID: 8095252)
1. Cervical neuroblastoma and multiple endocrine neoplasia type 2a.
Triglia JM; Bernard JL; Scheiner C
Int J Pediatr Otorhinolaryngol; 1993 Feb; 26(1):71-7. PubMed ID: 8095252
[TBL] [Abstract][Full Text] [Related]
2. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The Netherlands.
Vasen HF; Nieuwenhuijzen Kruseman AC; Berkel H; Beukers EK; Delprat CC; Van Doorn RG; Geerdink RA; Haak HR; Hackeng WH; Koppeschaar HP
Am J Med; 1987 Nov; 83(5):847-52. PubMed ID: 2890300
[TBL] [Abstract][Full Text] [Related]
4. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
5. [Endocrine polyadenomatosis of 2a type (MEN 2a). Clinical and genetic study of a family].
Guillausseau PJ; Guillausseau C; Calmettes C; Feingold N; Demenais F; Sobol H; Gony J; Hors J; Schaison G; Seret D
Ann Endocrinol (Paris); 1988; 49(1):17-21. PubMed ID: 2900619
[TBL] [Abstract][Full Text] [Related]
6. Prominent corneal nerves in patients with multiple endocrine neoplasia type 2A: diagnostic implications.
Takai S; Kinoshita S; Tanaka F; Ikeda M; Tanaka N; Kobayashi T
World J Surg; 1992; 16(4):620-3; discussion 624. PubMed ID: 1357828
[TBL] [Abstract][Full Text] [Related]
7. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
[TBL] [Abstract][Full Text] [Related]
10. [Multiple endocrine neoplasia type 2: familial variant of medullary carcinoma of the thyroid gland].
Neradilová M; Soutorová M; Vlcek P
Vnitr Lek; 1992 Sep; 38(9):850-9. PubMed ID: 1362306
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of medullary carcinoma of the thyroid.
Block MA
Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
[TBL] [Abstract][Full Text] [Related]
12. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
Wells SA; Chi DD; Toshima K; Dehner LP; Coffin CM; Dowton SB; Ivanovich JL; DeBenedetti MK; Dilley WG; Moley JF
Ann Surg; 1994 Sep; 220(3):237-47; discussion 247-50. PubMed ID: 7916559
[TBL] [Abstract][Full Text] [Related]
13. Genetics of the multiple endocrine neoplasia type 2B syndrome.
Jackson CE; Norum RA
Henry Ford Hosp Med J; 1992; 40(3-4):232-5. PubMed ID: 1362412
[TBL] [Abstract][Full Text] [Related]
14. Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Decker RA
Surgery; 1993 Dec; 114(6):1059-63. PubMed ID: 7903002
[TBL] [Abstract][Full Text] [Related]
15. Risk estimation and screening in families of patients with medullary thyroid carcinoma.
Ponder BA; Ponder MA; Coffey R; Pembrey ME; Gagel RF; Telenius-Berg M; Semple P; Easton DF
Lancet; 1988 Feb; 1(8582):397-401. PubMed ID: 2893198
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2].
Kuznetsov NS; Bel'tsevich DG; Poliakova EIu; Vasil'ev EV; Nemtsova MV
Khirurgiia (Mosk); 2002; (2):4-9. PubMed ID: 12418313
[TBL] [Abstract][Full Text] [Related]
17. Rare syndromes.
Jabbour SA; Davidovici BB; Wolf R
Clin Dermatol; 2006; 24(4):299-316. PubMed ID: 16828412
[TBL] [Abstract][Full Text] [Related]
18. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
Zwolak A; Rudzki G; Świrska J; Dudzińska M; Daniluk J; Tarach J
Endokrynol Pol; 2015; 66(5):462-8. PubMed ID: 26457501
[TBL] [Abstract][Full Text] [Related]
19. [Multiple endocrine neoplasia syndromes. Type 2].
Juodele L; Juozaityte E; Zindzius A; Pundzius J
Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
[TBL] [Abstract][Full Text] [Related]
20. Results of a screening program for multiple endocrine neoplasia type 2A: a clinical study of a Japanese family.
Shimotake T; Iwai N; Yanagihara J; Kobayashi T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):124-6. PubMed ID: 2576943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]